Structure

Physi-Chem Properties

Molecular Weight:  660.27
Volume:  700.412
LogP:  6.913
LogD:  3.606
LogS:  -3.035
# Rotatable Bonds:  15
TPSA:  141.36
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.073
Synthetic Accessibility Score:  4.317
Fsp3:  0.244
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.916
MDCK Permeability:  9.542735824652482e-06
Pgp-inhibitor:  0.0
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.862
20% Bioavailability (F20%):  0.987
30% Bioavailability (F30%):  0.049

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.0
Plasma Protein Binding (PPB):  102.78498840332031%
Volume Distribution (VD):  0.137
Pgp-substrate:  0.2698429524898529%

ADMET: Metabolism

CYP1A2-inhibitor:  0.017
CYP1A2-substrate:  0.697
CYP2C19-inhibitor:  0.122
CYP2C19-substrate:  0.875
CYP2C9-inhibitor:  0.899
CYP2C9-substrate:  0.999
CYP2D6-inhibitor:  0.063
CYP2D6-substrate:  0.178
CYP3A4-inhibitor:  0.103
CYP3A4-substrate:  0.581

ADMET: Excretion

Clearance (CL):  -0.358
Half-life (T1/2):  0.281

ADMET: Toxicity

hERG Blockers:  0.052
Human Hepatotoxicity (H-HT):  0.931
Drug-inuced Liver Injury (DILI):  0.954
AMES Toxicity:  0.02
Rat Oral Acute Toxicity:  0.971
Maximum Recommended Daily Dose:  0.98
Skin Sensitization:  0.113
Carcinogencity:  0.058
Eye Corrosion:  0.003
Eye Irritation:  0.019
Respiratory Toxicity:  0.266

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC323627

Natural Product ID:  NPC323627
Common Name*:   (+/-)-Chartaceone C
IUPAC Name:   (E)-7-[8-[(E)-6-carboxy-1-phenylhex-2-enyl]-5,7-dihydroxy-4-oxo-2-phenyl-2,3-dihydrochromen-6-yl]-7-phenylhept-5-enoic acid
Synonyms:   (+/-)-Chartaceone C
Standard InCHIKey:  RGZSPQYXJSDKAN-FWSOMWAYSA-N
Standard InCHI:  InChI=1S/C41H40O8/c42-32-26-33(29-20-10-3-11-21-29)49-41-37(31(28-18-8-2-9-19-28)23-13-5-15-25-35(45)46)39(47)36(40(48)38(32)41)30(27-16-6-1-7-17-27)22-12-4-14-24-34(43)44/h1-3,6-13,16-23,30-31,33,47-48H,4-5,14-15,24-26H2,(H,43,44)(H,45,46)/b22-12+,23-13+
SMILES:  OC(=O)CCC/C=C/C(c1c(O)c2C(=O)CC(Oc2c(c1O)C(c1ccccc1)/C=C/CCCC(=O)O)c1ccccc1)c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1940603
PubChem CID:   56834069
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11348 Cryptocarya chartacea Species Lauraceae Eukaryota n.a. trunk bark n.a. PMID[22050318]
NPO11348 Cryptocarya chartacea Species Lauraceae Eukaryota bark n.a. n.a. PMID[22050318]
NPO11348 Cryptocarya chartacea Species Lauraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens GI = 0.0 % PMID[459853]
NPT2 Others Unspecified IC50 = 4200.0 nM PMID[459853]
NPT2 Others Unspecified IC50 > 50000.0 nM PMID[459853]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC323627 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC322459
1.0 High Similarity NPC324358
1.0 High Similarity NPC318527
0.9667 High Similarity NPC121568
0.9605 High Similarity NPC1796
0.9605 High Similarity NPC257166
0.9542 High Similarity NPC51247
0.9542 High Similarity NPC15815
0.9533 High Similarity NPC78835
0.9533 High Similarity NPC309512
0.9533 High Similarity NPC204561
0.9533 High Similarity NPC317715
0.9533 High Similarity NPC316960
0.9533 High Similarity NPC148945
0.9481 High Similarity NPC42965
0.9481 High Similarity NPC98023
0.9481 High Similarity NPC226462
0.9481 High Similarity NPC195136
0.9474 High Similarity NPC79375
0.9474 High Similarity NPC37253
0.947 High Similarity NPC39154
0.947 High Similarity NPC115601
0.947 High Similarity NPC208011
0.947 High Similarity NPC78324
0.9416 High Similarity NPC105584
0.9412 High Similarity NPC32867
0.9412 High Similarity NPC69531
0.9404 High Similarity NPC178484
0.9359 High Similarity NPC473012
0.9355 High Similarity NPC121647
0.9351 High Similarity NPC475184
0.9351 High Similarity NPC208258
0.9346 High Similarity NPC182555
0.9346 High Similarity NPC66441
0.9346 High Similarity NPC300668
0.9346 High Similarity NPC134171
0.9342 High Similarity NPC174086
0.9333 High Similarity NPC122894
0.9299 High Similarity NPC473009
0.9295 High Similarity NPC312273
0.9295 High Similarity NPC175513
0.9295 High Similarity NPC301256
0.9295 High Similarity NPC114652
0.929 High Similarity NPC295090
0.9276 High Similarity NPC209142
0.9276 High Similarity NPC312549
0.9272 High Similarity NPC3642
0.9272 High Similarity NPC132345
0.9241 High Similarity NPC473010
0.9231 High Similarity NPC114147
0.9226 High Similarity NPC271741
0.9226 High Similarity NPC287789
0.9221 High Similarity NPC201227
0.9221 High Similarity NPC258474
0.9216 High Similarity NPC43345
0.92 High Similarity NPC228779
0.9182 High Similarity NPC251336
0.9172 High Similarity NPC97812
0.9167 High Similarity NPC51760
0.9161 High Similarity NPC56049
0.9161 High Similarity NPC61112
0.9161 High Similarity NPC198489
0.9161 High Similarity NPC54830
0.9161 High Similarity NPC309648
0.9156 High Similarity NPC324447
0.915 High Similarity NPC476551
0.915 High Similarity NPC476553
0.915 High Similarity NPC476552
0.9145 High Similarity NPC104236
0.9145 High Similarity NPC19238
0.9145 High Similarity NPC164205
0.9139 High Similarity NPC261271
0.9139 High Similarity NPC475348
0.9133 High Similarity NPC470136
0.9133 High Similarity NPC470135
0.9133 High Similarity NPC39045
0.9114 High Similarity NPC473011
0.9097 High Similarity NPC186227
0.9097 High Similarity NPC265624
0.9097 High Similarity NPC52611
0.9097 High Similarity NPC205026
0.9097 High Similarity NPC100049
0.9097 High Similarity NPC215203
0.9097 High Similarity NPC150908
0.9097 High Similarity NPC14606
0.9097 High Similarity NPC159707
0.9097 High Similarity NPC158027
0.9097 High Similarity NPC121649
0.9097 High Similarity NPC248739
0.9079 High Similarity NPC152233
0.9073 High Similarity NPC470134
0.9073 High Similarity NPC470131
0.9073 High Similarity NPC470132
0.9073 High Similarity NPC470133
0.9073 High Similarity NPC473078
0.9073 High Similarity NPC109183
0.9057 High Similarity NPC63438
0.9045 High Similarity NPC123544
0.9045 High Similarity NPC195167
0.9032 High Similarity NPC72425
0.9032 High Similarity NPC194593
0.9032 High Similarity NPC303485
0.9032 High Similarity NPC71061
0.9032 High Similarity NPC290830
0.9026 High Similarity NPC111112
0.9026 High Similarity NPC138299
0.9026 High Similarity NPC67322
0.9026 High Similarity NPC222713
0.902 High Similarity NPC288840
0.902 High Similarity NPC473016
0.902 High Similarity NPC291746
0.9018 High Similarity NPC168789
0.9007 High Similarity NPC282957
0.9007 High Similarity NPC235217
0.9007 High Similarity NPC271288
0.9007 High Similarity NPC194949
0.9007 High Similarity NPC473014
0.8987 High Similarity NPC292863
0.8987 High Similarity NPC184326
0.8961 High Similarity NPC474735
0.8957 High Similarity NPC477529
0.8954 High Similarity NPC145467
0.8947 High Similarity NPC127059
0.8947 High Similarity NPC25844
0.8947 High Similarity NPC285630
0.8947 High Similarity NPC181388
0.8947 High Similarity NPC470322
0.8944 High Similarity NPC224851
0.8944 High Similarity NPC320741
0.8944 High Similarity NPC171985
0.894 High Similarity NPC278249
0.894 High Similarity NPC85162
0.894 High Similarity NPC77794
0.894 High Similarity NPC81697
0.894 High Similarity NPC107177
0.894 High Similarity NPC223812
0.894 High Similarity NPC125894
0.894 High Similarity NPC185276
0.8938 High Similarity NPC38591
0.8933 High Similarity NPC248372
0.8933 High Similarity NPC110038
0.8931 High Similarity NPC137232
0.8931 High Similarity NPC92589
0.8931 High Similarity NPC18380
0.8924 High Similarity NPC55443
0.8924 High Similarity NPC90497
0.8924 High Similarity NPC18699
0.8917 High Similarity NPC471787
0.8903 High Similarity NPC290671
0.8896 High Similarity NPC76047
0.8896 High Similarity NPC476365
0.8896 High Similarity NPC469932
0.8889 High Similarity NPC296998
0.8889 High Similarity NPC10990
0.8889 High Similarity NPC283234
0.8889 High Similarity NPC473077
0.8889 High Similarity NPC300988
0.8889 High Similarity NPC140120
0.8889 High Similarity NPC308200
0.8882 High Similarity NPC196137
0.8882 High Similarity NPC131568
0.8882 High Similarity NPC131579
0.8882 High Similarity NPC473013
0.8882 High Similarity NPC471473
0.8882 High Similarity NPC471524
0.8882 High Similarity NPC471523
0.8882 High Similarity NPC178627
0.8882 High Similarity NPC197252
0.8882 High Similarity NPC236766
0.8882 High Similarity NPC1886
0.8882 High Similarity NPC473015
0.8882 High Similarity NPC469935
0.8875 High Similarity NPC15374
0.8874 High Similarity NPC125855
0.8874 High Similarity NPC228504
0.8874 High Similarity NPC107572
0.8874 High Similarity NPC167624
0.8874 High Similarity NPC227579
0.8874 High Similarity NPC324436
0.8874 High Similarity NPC220998
0.8874 High Similarity NPC223500
0.8874 High Similarity NPC64915
0.8874 High Similarity NPC296917
0.8874 High Similarity NPC166934
0.8874 High Similarity NPC1089
0.8874 High Similarity NPC161506
0.8874 High Similarity NPC265040
0.8874 High Similarity NPC37496
0.8874 High Similarity NPC328164
0.8874 High Similarity NPC32739
0.8874 High Similarity NPC324134
0.8874 High Similarity NPC10937
0.8874 High Similarity NPC76338
0.8874 High Similarity NPC182852
0.8874 High Similarity NPC148757
0.8874 High Similarity NPC78
0.8874 High Similarity NPC166482
0.8874 High Similarity NPC194432
0.8874 High Similarity NPC76372
0.8874 High Similarity NPC306829

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC323627 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9346 High Similarity NPD8443 Clinical (unspecified phase)
0.9241 High Similarity NPD7852 Clinical (unspecified phase)
0.9038 High Similarity NPD7768 Phase 2
0.9026 High Similarity NPD7411 Suspended
0.891 High Similarity NPD7819 Suspended
0.8861 High Similarity NPD7075 Discontinued
0.8812 High Similarity NPD6959 Discontinued
0.8758 High Similarity NPD7410 Clinical (unspecified phase)
0.8671 High Similarity NPD7096 Clinical (unspecified phase)
0.8667 High Similarity NPD1550 Clinical (unspecified phase)
0.8667 High Similarity NPD1552 Clinical (unspecified phase)
0.8609 High Similarity NPD1549 Phase 2
0.8599 High Similarity NPD4380 Phase 2
0.8516 High Similarity NPD4378 Clinical (unspecified phase)
0.8509 High Similarity NPD3749 Approved
0.8494 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8438 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8395 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8375 Intermediate Similarity NPD6801 Discontinued
0.8333 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD6166 Phase 2
0.8313 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8312 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8289 Intermediate Similarity NPD1510 Phase 2
0.8284 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8263 Intermediate Similarity NPD7473 Discontinued
0.8258 Intermediate Similarity NPD3750 Approved
0.8246 Intermediate Similarity NPD8313 Approved
0.8246 Intermediate Similarity NPD8312 Approved
0.8235 Intermediate Similarity NPD2796 Approved
0.8148 Intermediate Similarity NPD1934 Approved
0.8118 Intermediate Similarity NPD7074 Phase 3
0.8101 Intermediate Similarity NPD6799 Approved
0.8098 Intermediate Similarity NPD8455 Phase 2
0.8084 Intermediate Similarity NPD6232 Discontinued
0.8063 Intermediate Similarity NPD5403 Approved
0.8059 Intermediate Similarity NPD5844 Phase 1
0.8059 Intermediate Similarity NPD7054 Approved
0.8026 Intermediate Similarity NPD1240 Approved
0.8025 Intermediate Similarity NPD6599 Discontinued
0.8013 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8013 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8013 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7472 Approved
0.8 Intermediate Similarity NPD1551 Phase 2
0.7977 Intermediate Similarity NPD7808 Phase 3
0.7964 Intermediate Similarity NPD5494 Approved
0.7939 Intermediate Similarity NPD3817 Phase 2
0.7937 Intermediate Similarity NPD2532 Approved
0.7937 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7937 Intermediate Similarity NPD2533 Approved
0.7937 Intermediate Similarity NPD2534 Approved
0.7937 Intermediate Similarity NPD5401 Approved
0.7935 Intermediate Similarity NPD2799 Discontinued
0.7935 Intermediate Similarity NPD3748 Approved
0.7922 Intermediate Similarity NPD6651 Approved
0.7922 Intermediate Similarity NPD1607 Approved
0.7921 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD6559 Discontinued
0.7919 Intermediate Similarity NPD7251 Discontinued
0.7881 Intermediate Similarity NPD4908 Phase 1
0.7875 Intermediate Similarity NPD7390 Discontinued
0.7875 Intermediate Similarity NPD1511 Approved
0.7874 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD6797 Phase 2
0.7861 Intermediate Similarity NPD5953 Discontinued
0.7853 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD7458 Discontinued
0.7848 Intermediate Similarity NPD2800 Approved
0.7845 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD5402 Approved
0.7812 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7809 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD3818 Discontinued
0.7778 Intermediate Similarity NPD1512 Approved
0.7778 Intermediate Similarity NPD2313 Discontinued
0.7771 Intermediate Similarity NPD2801 Approved
0.7771 Intermediate Similarity NPD5408 Approved
0.7771 Intermediate Similarity NPD5404 Approved
0.7771 Intermediate Similarity NPD5406 Approved
0.7771 Intermediate Similarity NPD2935 Discontinued
0.7771 Intermediate Similarity NPD5405 Approved
0.7746 Intermediate Similarity NPD7286 Phase 2
0.7744 Intermediate Similarity NPD3226 Approved
0.7742 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD5124 Phase 1
0.7736 Intermediate Similarity NPD1243 Approved
0.773 Intermediate Similarity NPD920 Approved
0.7716 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD7003 Approved
0.7688 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD4628 Phase 3
0.7679 Intermediate Similarity NPD3882 Suspended
0.767 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD6832 Phase 2
0.7611 Intermediate Similarity NPD4287 Approved
0.761 Intermediate Similarity NPD2346 Discontinued
0.7579 Intermediate Similarity NPD8151 Discontinued
0.7578 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD1203 Approved
0.756 Intermediate Similarity NPD1465 Phase 2
0.7558 Intermediate Similarity NPD7229 Phase 3
0.7548 Intermediate Similarity NPD3268 Approved
0.7547 Intermediate Similarity NPD6099 Approved
0.7547 Intermediate Similarity NPD6100 Approved
0.7541 Intermediate Similarity NPD4360 Phase 2
0.7541 Intermediate Similarity NPD4363 Phase 3
0.7533 Intermediate Similarity NPD1610 Phase 2
0.75 Intermediate Similarity NPD2344 Approved
0.75 Intermediate Similarity NPD8150 Discontinued
0.7484 Intermediate Similarity NPD7033 Discontinued
0.7457 Intermediate Similarity NPD5710 Approved
0.7457 Intermediate Similarity NPD5711 Approved
0.7451 Intermediate Similarity NPD2797 Approved
0.7417 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7409 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7409 Intermediate Similarity NPD7783 Phase 2
0.7407 Intermediate Similarity NPD7435 Discontinued
0.7399 Intermediate Similarity NPD7199 Phase 2
0.7391 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD7177 Discontinued
0.7384 Intermediate Similarity NPD919 Approved
0.7375 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD7871 Phase 2
0.7368 Intermediate Similarity NPD7870 Phase 2
0.7356 Intermediate Similarity NPD3787 Discontinued
0.7349 Intermediate Similarity NPD6273 Approved
0.7348 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD6798 Discontinued
0.7325 Intermediate Similarity NPD3764 Approved
0.7317 Intermediate Similarity NPD2309 Approved
0.7316 Intermediate Similarity NPD7696 Phase 3
0.7316 Intermediate Similarity NPD7697 Approved
0.7316 Intermediate Similarity NPD7698 Approved
0.7314 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD7097 Phase 1
0.731 Intermediate Similarity NPD4288 Approved
0.7308 Intermediate Similarity NPD8434 Phase 2
0.7296 Intermediate Similarity NPD6355 Discontinued
0.729 Intermediate Similarity NPD2798 Approved
0.7288 Intermediate Similarity NPD3751 Discontinued
0.7288 Intermediate Similarity NPD7228 Approved
0.7273 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD3225 Approved
0.7268 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD7874 Approved
0.7255 Intermediate Similarity NPD9717 Approved
0.7255 Intermediate Similarity NPD1608 Approved
0.7249 Intermediate Similarity NPD6776 Approved
0.7249 Intermediate Similarity NPD6777 Approved
0.7249 Intermediate Similarity NPD6782 Approved
0.7249 Intermediate Similarity NPD6780 Approved
0.7249 Intermediate Similarity NPD6778 Approved
0.7249 Intermediate Similarity NPD6781 Approved
0.7249 Intermediate Similarity NPD6779 Approved
0.7235 Intermediate Similarity NPD5890 Approved
0.7235 Intermediate Similarity NPD5889 Approved
0.7226 Intermediate Similarity NPD3267 Approved
0.7226 Intermediate Similarity NPD3266 Approved
0.7219 Intermediate Similarity NPD4361 Phase 2
0.7219 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD3926 Phase 2
0.7202 Intermediate Similarity NPD7584 Approved
0.7202 Intermediate Similarity NPD7427 Discontinued
0.7193 Intermediate Similarity NPD37 Approved
0.719 Intermediate Similarity NPD422 Phase 1
0.7188 Intermediate Similarity NPD8319 Approved
0.7188 Intermediate Similarity NPD8320 Phase 1
0.7186 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD6234 Discontinued
0.7178 Intermediate Similarity NPD6005 Phase 3
0.7178 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD6004 Phase 3
0.7178 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD6002 Phase 3
0.7168 Intermediate Similarity NPD4965 Approved
0.7168 Intermediate Similarity NPD4967 Phase 2
0.7168 Intermediate Similarity NPD4966 Approved
0.7165 Intermediate Similarity NPD7701 Phase 2
0.716 Intermediate Similarity NPD4308 Phase 3
0.7158 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1548 Phase 1
0.7143 Intermediate Similarity NPD7801 Approved
0.7143 Intermediate Similarity NPD7700 Phase 2
0.7143 Intermediate Similarity NPD7699 Phase 2
0.7126 Intermediate Similarity NPD8005 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD943 Approved
0.7118 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD1164 Approved
0.7105 Intermediate Similarity NPD8285 Discontinued
0.7102 Intermediate Similarity NPD8127 Discontinued
0.7093 Intermediate Similarity NPD7577 Discontinued
0.7083 Intermediate Similarity NPD6823 Phase 2
0.7083 Intermediate Similarity NPD7447 Phase 1
0.7081 Intermediate Similarity NPD1933 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data